-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Elicio Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2020 to 2023.
- Elicio Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $82K, a 25.5% decline year-over-year.
- Elicio Therapeutics, Inc. annual Depreciation for 2023 was $382K, a 2.05% decline from 2022.
- Elicio Therapeutics, Inc. annual Depreciation for 2022 was $390K, a 329% increase from 2021.
- Elicio Therapeutics, Inc. annual Depreciation for 2021 was $91K, a 7.14% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)